Detection and localization of proteinuria by dynamic contrast-enhanced magnetic resonance imaging using MS325

Journal of the American Society of Nephrology

Volumn 16, Issue 6, 2005, Pages 1752-1757

  Zhang, Yantian ^a   Choyke, Peter L ^a   Lu, Huiyan ^b   Takahashi, Hideko ^b   Mannon, Roslyn B ^b   Zhang, Xiaojie ^b   Marcos, Hani ^a   Li, King C P ^a   Kopp, Jeffrey B ^b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; PUROMYCIN AMINONUCLEOSIDE; SODIUM CHLORIDE; DIAGNOSTIC AGENT; GADOFOSVESET; ORGANOMETALLIC COMPOUND; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; GLOMERULUS; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEINURIA; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; METHODOLOGY; NEPHROSIS;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MODELS, ANIMAL; NEPHROSIS; ORGANOMETALLIC COMPOUNDS; PROTEIN SYNTHESIS INHIBITORS; PROTEINURIA; PUROMYCIN AMINONUCLEOSIDE; RATS;

EID: 26944470848     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004110981     Document Type: Article

References (21)

1. Maack T: Renal filtration, transport, and metabolism of proteins. In: The Kidney: Physiology and Pathophysiology, Vol. 2, 3rd Ed., edited by Seldin DW, Giebisch G, Philadelphia, Lippincott, 2000, pp 2236-2267
2. Brunskill N: Mechanisms of albumin uptake by proximal tubular cells. Am J Kidney Dis 37: S17-S20, 2001
3. Kitiyakara C, Eggers P, Kopp JB: Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 44: 815-825, 2004
4. Dantal J, Soulillou JP: Relapse of focal segmental glomerulosclerosis after kidney transplantation. Adv Nephrol Necker Hosp 25: 91-106, 1996
5. Savin VJ, McCarthy ET, Sharma M: Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol 23: 147-160, 2003
6. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F: Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 92: 375-383, 1992
7. Andresdottir MB, Ajubi N, Croockewit S, Assmann KJ, Hibrands LB, Wetzels JF: Recurrent focal glomerulosclerosis: Natural course and treatment with plasma exchange. Nephrol Dial Transplant 14: 2650-2656, 1999
8. Dall'Amico R, Ghiggeri G, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F: Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34: 1048-1055, 1999
9. Caravan P, Comuzzi C, Crooks W, McMurry TJ, Choppin GR, Woulfe SR: Thermodynamic stability and kinetic inertness of MS-325, a new blood pool agent for magnetic resonance imaging. Inorg Chem 40: 2170-2176, 2001
10. Parmelee DJ, Walovitch RC, Quellet HS, Lauffer RB: Pre-clinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 32: 741-747, 1997
11. Weinmann HJ, Bauer H, Ebert W, Frenzel T, Raduchel B, Platzek J, Schmitt-Willich H: Comparative studies on the efficacy of MRI contrast agents in MRA. Acad Radiol 9[Suppl 1]: S135-S136, 2002
12. Schmiedl U, Brasch RC, Ogan MD, Moseley ME: Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. Acta Radiol Suppl 374: 99-102, 1990
13. Lahti KM, Lauffer RB, Chan T, Weisskoff RM: Magnetic resonance angiography at 0.3 T using MS-325. Magma 12: 88-91, 2001
14. Turetschek K, Floyd E, Helbich T, Roberts TP, Shames DM, Wendland MF, Carter WO, Brasch RC: MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. J Magn Reson Imaging 14: 237-242, 2001
15. Adzamli K, Yablonskiy DA, Chicoine MR, Won EK, Galen KP, Zahner MC, Woolsey TA, Ackerman JJ: Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model. Magn Reson Med 49: 586-590, 2003
16. Herborn CU, Waldschuetz R, Lauenstein TC, Goyen M, Lauffer RB, Moeroey T, Debatin JF, Ruehm SG: Contrast-enhanced magnetic resonance imaging (MS-325) in a murine model of systemic lupus erythematosus. Invest Radiol 37: 464-469, 2002
17. Deliganis AV, Maravilla KR, Heiman JR, Carter WO, Garland PA, Peterson BT, Hackbert L, Cao Y, Weisskoff RM: Female genitalia: Dynamic MR imaging with use of MS-325 initial experiences evaluating female sexual response. Radiology 225: 791-799, 2002
18. Sharafuddin MJ, Stolpen AH, Dang YM, Andresen KJ, Roh BS: Comparison of MS-325- and gadodiamide-enhanced MR venography of iliocaval veins. J Vasc Interv Radiol 13: 1021-1027, 2002
19. Vernier RL, Papermaster BW, Good RA: Aminonucleoside nephrosis I. Electron microscopic study of the renal lesion in rats. J Exp Med 109: 115, 1959
20. Mannon RB, Sundar SK, Sanfilippo FP, Coffman TM: Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. Transplantation 56: 1157-1162, 1993
21. Fabre J, Lim SH, Morris PJ: Renal transplantation in the rat: Details of a technique. Aust N Z J Surg 41: 69-75, 1971